EUVIMEDEUVIMED entdecken
Crossref

Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production

Xiaowei Wang, Shinya Satoh, Mengyu Jiao, Alu Konno, Masahiko Ito, Ayato Sato, Naoya Kadofusa, Yasumasa Iwatani, Tetsuro Suzuki

Biochemical and Biophysical Research Communications · 2026-09 · 829 · 154182

DOI: 10.1016/j.bbrc.2026.154182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Xiaowei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan. Hauptthemen laut MEDLINE: Hepacivirus, Antiviral Agents, Quinazolines, Virus Replication. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host-directed antiviral strategies provide an alternative approach to overcome the rapid emergence of drug-resistant viruses. Fatty acid synthase (FASN), a key enzyme in de novo lipogenesis, is exploited by multiple viruses to support their life cycles. To date, FASN-targeted therapies have focused on enzyme activity inhibition. However, since catalytic inhibition of FASN carries the risk of disrupting lipid homeostasis in normal tissues, FASN expression suppression was considered a potentially effective alternative. To identify inhibitors of FASN expression, we established a CRISPR-engineered HuH-7 reporter cell line in which a HiBiT tag was knocked into the endogenous FASN locus, enabling quantitative monitoring of native FASN protein levels. The high-throughput screening of 19,912 small molecules resulted in the identification of a potent suppressor of FASN production: an isoquinoline-derived quinazoline hybrid designated IQZ-1. Promoter analyses revealed that IQZ-1 inhibits FASN transcription at least via the proximal sterol regulatory elements of the FASN promoter. Using hepatitis C virus (HCV) as a lipid-dependent model virus, we demonstrated that IQZ-1 significantly reduced intracellular viral RNA levels and markedly suppressed infectious particle production. Subgenomic replicon analyses indicated partial inhibition of viral genome replication, while immunofluorescence studies revealed reduced abundance of lipid droplets, essential platforms for HCV virion formation, in infected cells. These findings suggest that transcriptional suppression of FASN impairs both membrane-associated replication complex formation and virion assembly. Collectively, our results establish proof of concept that targeting FASN synthesis, rather than enzymatic activity, effectively disrupts lipid-dependent viral propagation and represents a promising host-directed antiviral strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusAntiviral AgentsQuinazolinesVirus ReplicationIsoquinolinesFatty Acid Synthase, Type IFatty Acid SynthasesEnzyme InhibitorsHumansTranscription, GeneticCell Line, TumorPromoter Regions, Genetic

Stichwörter der Autor:innen

Fatty acid synthaseHepatitis C virusHigh-throughput screeningHost-directed antiviralIsoquinoline-derived quinazoline hybridLipid metabolism

Substanzen

Antiviral AgentsQuinazolinesIsoquinolinesFatty Acid Synthase, Type IFatty Acid SynthasesFASN protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan; Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan. Ele…
  • Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Aichi, Japan; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Aichi, Japan.
  • Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Aichi, Japan.
  • Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan; Next Generation Creative Education Center for Medicine, Engineering, and Informatics, Hamamatsu University School of M…

Förderung

  • Government of Japan Ministry of Education Culture Sports Science and Technology
  • AMED

Zitieren

APA

Wang, X., Satoh, S., Jiao, M., Konno, A., Ito, M., Sato, A., Kadofusa, N., Iwatani, Y., & Suzuki, T. (2026). Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production. Biochemical and Biophysical Research Communications, 829, 154182. https://doi.org/10.1016/j.bbrc.2026.154182

Vancouver

Wang X, Satoh S, Jiao M, Konno A, Ito M, Sato A, et al. Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production. Biochemical and Biophysical Research Communications. 2026;829:154182. doi:10.1016/j.bbrc.2026.154182

BibTeX
@article{Wang2026,
  author = {Wang, Xiaowei and Satoh, Shinya and Jiao, Mengyu and Konno, Alu and Ito, Masahiko and Sato, Ayato and Kadofusa, Naoya and Iwatani, Yasumasa and Suzuki, Tetsuro},
  title = {Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {829},
  pages = {154182},
  doi = {10.1016/j.bbrc.2026.154182}
}
Kostenlos starten →